ArticleThe Journal of innovations in cardiac rhythm management2026
Right Ventricular Implantation of an Aveir™ AR Device for Bradycardia in a 90-Year-Old Woman with Atrial Fibrillation and Small Right Ventricular Dimensions.
Article in The Journal of innovations in cardiac rhythm management, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Letter from the Editor in Chief.The Journal of innovations in cardiac rhythm management · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report a case of implanting an Aveir™ AR (atrial) leadless pacemaker (Abbott, Chicago, IL, USA) in the right ventricle (RV) of a 90-year-old woman with permanent atrial fibrillation with pauses. The patient initially received an Aveir™ VR (ventricular) device for rate support. During implantation, elevated pacing thresholds and tricuspid valve (TV) interaction were noted, which improved with repositioning. The patient subsequently presented with recurrent loss of capture secondary to elevated thresholds. Device interrogation and imaging suggested that the Aveir™ VR device was suboptimal due to the patient's small RV cavity and interaction with TV. To address this, the pacemaker was extracted, and an Aveir™ AR device-featuring a smaller profile-was successfully implanted in the RV, achieving stable fixation. To the best of our knowledge, this is the first reported case of off-label RV implantation of an Aveir™ AR device. This case illustrates the versatility of modular leadless pacing systems and underscores the importance of tailoring device selection to individual cardiac anatomy, particularly TV, in elderly patients with small RV dimensions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.